.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2018-003565-33-FR

Enrollment

120

Registered

2018-11-30

Start date

2019-02-14

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: METHYLPREDNISOLONE Pharmaceutical Form: Concentrate for solution for injection Trade Name: CHLORURE DE SODIUM Pharmaceutical Form: Solution for injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: D15	—

Countries

France

Contacts

Public ContactLise LACLAUTRE

CHU de Clermont-Ferrand

drci@chu-clermontferrand.fr+33473.754.963

Outcome results